
Procter & Gamble reported better-than-expected Q3 results with revenue of $21.2 billion, surpassing estimates due to strong beauty product sales and steady growth in household staples. Organic sales grew 3%, with beauty up 7% and baby, feminine, and family care rising 3%. Despite inflation and higher costs, volume increased 2%, showing resilient consumer demand. P&G maintained its fiscal 2026 guidance, expecting adjusted EPS between $6.83 and $7.09, and plans $10 billion in dividends and $5 billion in share buybacks.